Skip to main content
OpenTrials

Clinical trial condition

Connective Tissue Diseases

Explore clinical trials studying Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

5,734 public trials 875 recruiting studies
Refine in advanced search Browse all conditions

Connective Tissue Diseases trial results

Completed

Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients

NCT00146770

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +12 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • University of Rochester Rochester, New York, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View all 25 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus

NCT02391259

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Research Site Anniston, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
View all 13 locations
View Trial Details
Completed

Double Blind, Placebo-controlled, Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients

NCT00669942

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Novartis Investigative Site Anniston, Alabama, United States
  • Novartis Investigative Site Tucson, Arizona, United States
  • Novartis Investigative Site Largo, Florida, United States
  • Novartis Investigative Site Ocala, Florida, United States
View all 24 locations
View Trial Details
Completed

A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)

NCT00443443

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Rheumatology Associates, PC Birmingham, Alabama, United States
  • Rheumatology Associates of N. AL, P.C. Huntsville, Alabama, United States
  • Clinic for Rheumatic Diseases - Research Department Tuscaloosa, Alabama, United States
  • Arizona Arthritis and Rheumatology Research, PLLC Paradise Valley, Arizona, United States
View all 193 locations
View Trial Details
Completed

Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis

NCT00095147

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Local Institution Huntsville, Alabama, United States
  • Local Institution Denver, Colorado, United States
  • Local Institution Boca Raton, Florida, United States
  • Local Institution Fort Lauderdale, Florida, United States
View all 76 locations
View Trial Details
Completed

Phase IIIB Subcutaneous Abatacept Monotherapy Study

NCT00547521

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Rheumatology Associates Of North Alabama Huntsville, Alabama, United States
  • Coastal Clinical Research Inc Mobile, Alabama, United States
  • Stanford University School Of Medicine Palo Alto, California, United States
  • Boulder Medical Center Boulder, Colorado, United States
View all 22 locations
View Trial Details

Related conditions